Home>Topics>Finance>Ceos>Brenda Barnes

Brenda Barnes

  1. All
  2. Commentary
  1. As Potential Bidders Sit on the Sidelines, Sara Lee Reportedly Looks to Split Up Its Business

    Commentary

    Thu, 27 Jan 2011

    continuing to operate as a going concern) remains in place. With corporate oversight questions looming since CEO Brenda Barnes stepped down for health reasons in August, Sara Lee has been in limbo, garnering interest from financial and strategic

  2. Despite Sale of Global Shoe-Care Business, Sara Lee Remains Overvalued

    Commentary

    Mon, 3 Jan 2011

    product firm to be a takeover target, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making it vulnerable to bids. With its shares now trading at around 9

  3. Sara Lee Continues to Shed Household Brands but Remains Takeover Target, in Our View

    Commentary

    Tue, 28 Dec 2010

    product firm to be a takeover target, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making it vulnerable to bids. With its shares now trading at around 9

  4. In Line With Our Thinking, Sara Lee Rumored to Be Shopping Itself, but Shares Look Rich

    Commentary

    Mon, 20 Dec 2010

    both strategic and financial suitors, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making the firm vulnerable to bids. Beyond looking to sell the combined

  5. Sara Lee Shakes Off Achilles' Heel, but Still Struggles in 1Q

    Commentary

    Tue, 9 Nov 2010

    divestiture of the lower-margin bakery segment, and corporate oversight questions linger following the departure of CEO Brenda Barnes for health reasons in August. Although the divestiture of the bakery business may actually deter private equity firms

  6. Sara Lee Jumps on Private Equity Takeover Rumors

    Commentary

    Mon, 4 Oct 2010

    range) and debt/EBITDA of less than 2 times. In addition, the firm has been in limbo since the departure of CEO Brenda Barnes for health reasons in August, and KKR may consider this a window of opportunity. We would expect a private equity

  7. Barnes to Step Down as Sara Lee CEO

    Commentary

    Mon, 9 Aug 2010

    On Monday, Sara Lee SLE announced that Brenda Barnes is stepping down from the CEO position, after suffering from a stroke in May. CFO Marcel Smits will continue to serve as interim

  8. Sara Lee to Sell Insecticide Brands

    Commentary

    Tue, 15 Jun 2010

    consistent sales and operating profit growth, which has been the firm's Achilles' heel over the past several years. CEO Brenda Barnes is on medical leave, recovering from a stroke. We expect to garner additional details on her condition when Sara

  9. Sara Lee CEO to Take Leave

    Commentary

    Mon, 17 May 2010

    On Friday , Sara Lee SLE announced that CEO Brenda Barnes is taking a temporary leave of absence for medical reasons . CFO Marcel Smits will assume the CEO duties , and lead independent

  10. Sara Lee Reports Mixed 4Q

    Commentary

    Wed, 15 Aug 2007

    overpromising and underdelivering on its long-term targets. Things have not improved much in the past year, with CEO Brenda Barnes and her management team struggling to regain their credibility with investors and analysts alike. And with the firm

« Prev12Next »
Content Partners